Market Trends PTC Therapeutics submits NDA for Friedreich ataxia treatment vatiquinoneBy admin8996erT0allDecember 19, 2024 Shidlovski PTC Therapeutics (NASDAQ:PTCT) has submitted a New Drug Application to the U.S. FDA seeking approval of its Friedreich ataxia…